Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  37,764 results for ""ATOMOXETINE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Development and In vivo Evaluation of Atomoxetine Hydrochloride ODMTs in a Nicotine-induced Attention Deficit Hyperactivity Disorder (ADHD) Model in Rats.

  • Authors : Atalay Ö; Faculty of Medicine, Department of Physiology, Hacettepe University, Ankara, Türkiye.; Ozyilmaz ED

Subjects: Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/pharmacology ; Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/administration & dosage ; Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/drug therapy

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Jul 31; Vol. 25 (6), pp. 173. Date of Electronic Publication: 2024 Jul 31.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

Read More Add to Saved list
×
Academic Journal

Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD.

Subjects: Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/adverse effects ; Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/drug therapy ; Adrenergic Uptake Inhibitors*/Adrenergic Uptake Inhibitors*/Adrenergic Uptake Inhibitors*/adverse effects

  • Source: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 Jul-Aug 01; Vol. 44 (4), pp. 434-436. Date of Electronic Publication: 2024 Jun 21.Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy.

  • Authors : Schein J; Otsuka Pharmaceutical Development & Commercialization, Inc., 508 Carnegie Center, Princeton, NJ 08540, USA.; Cloutier M

Subjects: Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/drug therapy ; Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/therapeutic use ; Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/adverse effects

  • Source: Journal of comparative effectiveness research [J Comp Eff Res] 2024 Sep; Vol. 13 (9), pp. e240089. Date of Electronic Publication: 2024 Aug 12.Publisher: Becaris Publishing Country of Publication: England NLM ID: 101577308 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetine.

  • Authors : Jolly RA; Eli Lilly and Company, Inc. Indianapolis, IN, 46285, USA. Electronic address: .; Cornwell PD

Subjects: Duloxetine Hydrochloride*/Duloxetine Hydrochloride*/Duloxetine Hydrochloride*/toxicity ; Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/toxicity ; Fluoxetine*/Fluoxetine*/Fluoxetine*/toxicity

  • Source: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2024 Sep; Vol. 152, pp. 105672. Date of Electronic Publication: 2024 Jul 04.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8214983 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Development of a fluorescent nano-sensing probe for atomoxetine analysis: Additional clinical pharmacokinetic study.

  • Authors : Alosaimi ME; Department of Basic Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.; Abduljabbar MH

Subjects: Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/pharmacokinetics ; Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/blood ; Quantum Dots*/Quantum Dots*/Quantum Dots*/chemistry

  • Source: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Dec 05; Vol. 322, pp. 124793. Date of Electronic Publication: Publisher: Elsevier Country of Publication: England NLM ID: 9602533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3557

Record details

Read More Add to Saved list
×
Academic Journal

Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment.

  • Authors : Dammer EB; Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30322, USA.; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/genetics

  • Source: Science translational medicine [Sci Transl Med] 2024 Jun 26; Vol. 16 (753), pp. eadn3504. Date of Electronic Publication: 2024 Jun 26.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Assessment of centanafadine in adults with attention-deficit/hyperactivity disorder: A matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release.

  • Authors : Schein J; Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ.; Cloutier M

Subjects: Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/adverse effects ; Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/therapeutic use ; Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/drug therapy

  • Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Jun; Vol. 30 (6), pp. 528-540.Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and Safety of Methylphenidate and Atomoxetine in Medication-Naive Children with Attention-Deficit Hyperactivity Disorder in a Real-World Setting.

  • Authors : Zhang Y; Department of Child Healthcare, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.; Yin L

Subjects: Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/therapeutic use ; Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/adverse effects ; Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/Attention Deficit Disorder with Hyperactivity*/drug therapy

  • Source: Drugs in R&D [Drugs R D] 2024 Mar; Vol. 24 (1), pp. 29-39. Date of Electronic Publication: 2023 Nov 20.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment.

  • Authors : Qu S; Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China. .; Chinese Institute for Brain Research, Beijing, China. .

Subjects: Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/Atomoxetine Hydrochloride*/pharmacology ; Methylphenidate*/Methylphenidate*/Methylphenidate*/pharmacology ; Drosophila melanogaster*/Drosophila melanogaster*/Drosophila melanogaster*/drug effects

  • Source: Molecular psychiatry [Mol Psychiatry] 2024 Jan; Vol. 29 (1), pp. 165-185. Date of Electronic Publication: 2023 Nov 13.Publisher: Nature Publishing Group Specialist Journals Country of Publication: England NLM ID: 9607835 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Norepinephrine Reuptake Inhibition, an Emergent Treatment for Neurogenic Orthostatic Hypotension.

  • Authors : Mwesigwa N; Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (N.M., C.A.S.).; Shibao CA

Subjects: Hypotension, Orthostatic*/Hypotension, Orthostatic*/Hypotension, Orthostatic*/drug therapy ; Hypotension, Orthostatic*/Hypotension, Orthostatic*/Hypotension, Orthostatic*/physiopathology ; Adrenergic Uptake Inhibitors*/Adrenergic Uptake Inhibitors*/Adrenergic Uptake Inhibitors*/therapeutic use

  • Source: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2024 Jul; Vol. 81 (7), pp. 1460-1466. Date of Electronic Publication: 2024 May 20.Publisher: Lippincott, Williams & Wilkins Country of Publication: United States NLM ID: 7906255 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  37,764 results for ""ATOMOXETINE""